IRF3 promotes adipose inflammation and insulin resistance and represses browning

Manju Kumari, Xun Wang, Louise Lantier, Anna Lyubetskaya, Jun Eguchi, Sona Kang, Danielle Tenen, Hyun Cheol Roh, Xingxing Kong, Lawrence Kazak, Rasheed Ahmad, Evan D. Rosen

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The chronic inflammatory state that accompanies obesity is a major contributor to insulin resistance and other dysfunctional adaptations in adipose tissue. Cellular and secreted factors promote the inflammatory milieu of obesity, but the transcriptional pathways that drive these processes are not well described. Although the canonical inflammatory transcription factor NF-κB is considered to be the major driver of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play a role in this process. Here, we determined that IRF3 expression is upregulated in the adipocytes of obese mice and humans. Signaling through TLR3 and TLR4, which lie upstream of IRF3, induced insulin resistance in murine adipocytes, while IRF3 knockdown prevented insulin resistance. Furthermore, improved insulin sensitivity in IRF3-deficient mice was associated with reductions in intra-adipose and systemic inflammation in the high fat-fed state, enhanced browning of subcutaneous fat, and increased adipose expression of GLUT4. Taken together, the data indicate that IRF3 is a major transcriptional regulator of adipose inflammation and is involved in maintaining systemic glucose and energy homeostasis.

Original languageEnglish
Pages (from-to)2839-2854
Number of pages16
JournalJournal of Clinical Investigation
Volume126
Issue number8
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Insulin Resistance
Adipocytes
Inflammation
Obesity
Interferon Regulatory Factors
Obese Mice
Subcutaneous Fat
Adipose Tissue
Homeostasis
Transcription Factors
Fats
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kumari, M., Wang, X., Lantier, L., Lyubetskaya, A., Eguchi, J., Kang, S., ... Rosen, E. D. (2016). IRF3 promotes adipose inflammation and insulin resistance and represses browning. Journal of Clinical Investigation, 126(8), 2839-2854. https://doi.org/10.1172/JCI86080

IRF3 promotes adipose inflammation and insulin resistance and represses browning. / Kumari, Manju; Wang, Xun; Lantier, Louise; Lyubetskaya, Anna; Eguchi, Jun; Kang, Sona; Tenen, Danielle; Roh, Hyun Cheol; Kong, Xingxing; Kazak, Lawrence; Ahmad, Rasheed; Rosen, Evan D.

In: Journal of Clinical Investigation, Vol. 126, No. 8, 01.08.2016, p. 2839-2854.

Research output: Contribution to journalArticle

Kumari, M, Wang, X, Lantier, L, Lyubetskaya, A, Eguchi, J, Kang, S, Tenen, D, Roh, HC, Kong, X, Kazak, L, Ahmad, R & Rosen, ED 2016, 'IRF3 promotes adipose inflammation and insulin resistance and represses browning', Journal of Clinical Investigation, vol. 126, no. 8, pp. 2839-2854. https://doi.org/10.1172/JCI86080
Kumari, Manju ; Wang, Xun ; Lantier, Louise ; Lyubetskaya, Anna ; Eguchi, Jun ; Kang, Sona ; Tenen, Danielle ; Roh, Hyun Cheol ; Kong, Xingxing ; Kazak, Lawrence ; Ahmad, Rasheed ; Rosen, Evan D. / IRF3 promotes adipose inflammation and insulin resistance and represses browning. In: Journal of Clinical Investigation. 2016 ; Vol. 126, No. 8. pp. 2839-2854.
@article{e2a196e8e5b24446b5e5cb3224eba21f,
title = "IRF3 promotes adipose inflammation and insulin resistance and represses browning",
abstract = "The chronic inflammatory state that accompanies obesity is a major contributor to insulin resistance and other dysfunctional adaptations in adipose tissue. Cellular and secreted factors promote the inflammatory milieu of obesity, but the transcriptional pathways that drive these processes are not well described. Although the canonical inflammatory transcription factor NF-κB is considered to be the major driver of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play a role in this process. Here, we determined that IRF3 expression is upregulated in the adipocytes of obese mice and humans. Signaling through TLR3 and TLR4, which lie upstream of IRF3, induced insulin resistance in murine adipocytes, while IRF3 knockdown prevented insulin resistance. Furthermore, improved insulin sensitivity in IRF3-deficient mice was associated with reductions in intra-adipose and systemic inflammation in the high fat-fed state, enhanced browning of subcutaneous fat, and increased adipose expression of GLUT4. Taken together, the data indicate that IRF3 is a major transcriptional regulator of adipose inflammation and is involved in maintaining systemic glucose and energy homeostasis.",
author = "Manju Kumari and Xun Wang and Louise Lantier and Anna Lyubetskaya and Jun Eguchi and Sona Kang and Danielle Tenen and Roh, {Hyun Cheol} and Xingxing Kong and Lawrence Kazak and Rasheed Ahmad and Rosen, {Evan D.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1172/JCI86080",
language = "English",
volume = "126",
pages = "2839--2854",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "8",

}

TY - JOUR

T1 - IRF3 promotes adipose inflammation and insulin resistance and represses browning

AU - Kumari, Manju

AU - Wang, Xun

AU - Lantier, Louise

AU - Lyubetskaya, Anna

AU - Eguchi, Jun

AU - Kang, Sona

AU - Tenen, Danielle

AU - Roh, Hyun Cheol

AU - Kong, Xingxing

AU - Kazak, Lawrence

AU - Ahmad, Rasheed

AU - Rosen, Evan D.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The chronic inflammatory state that accompanies obesity is a major contributor to insulin resistance and other dysfunctional adaptations in adipose tissue. Cellular and secreted factors promote the inflammatory milieu of obesity, but the transcriptional pathways that drive these processes are not well described. Although the canonical inflammatory transcription factor NF-κB is considered to be the major driver of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play a role in this process. Here, we determined that IRF3 expression is upregulated in the adipocytes of obese mice and humans. Signaling through TLR3 and TLR4, which lie upstream of IRF3, induced insulin resistance in murine adipocytes, while IRF3 knockdown prevented insulin resistance. Furthermore, improved insulin sensitivity in IRF3-deficient mice was associated with reductions in intra-adipose and systemic inflammation in the high fat-fed state, enhanced browning of subcutaneous fat, and increased adipose expression of GLUT4. Taken together, the data indicate that IRF3 is a major transcriptional regulator of adipose inflammation and is involved in maintaining systemic glucose and energy homeostasis.

AB - The chronic inflammatory state that accompanies obesity is a major contributor to insulin resistance and other dysfunctional adaptations in adipose tissue. Cellular and secreted factors promote the inflammatory milieu of obesity, but the transcriptional pathways that drive these processes are not well described. Although the canonical inflammatory transcription factor NF-κB is considered to be the major driver of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play a role in this process. Here, we determined that IRF3 expression is upregulated in the adipocytes of obese mice and humans. Signaling through TLR3 and TLR4, which lie upstream of IRF3, induced insulin resistance in murine adipocytes, while IRF3 knockdown prevented insulin resistance. Furthermore, improved insulin sensitivity in IRF3-deficient mice was associated with reductions in intra-adipose and systemic inflammation in the high fat-fed state, enhanced browning of subcutaneous fat, and increased adipose expression of GLUT4. Taken together, the data indicate that IRF3 is a major transcriptional regulator of adipose inflammation and is involved in maintaining systemic glucose and energy homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=84987786665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987786665&partnerID=8YFLogxK

U2 - 10.1172/JCI86080

DO - 10.1172/JCI86080

M3 - Article

VL - 126

SP - 2839

EP - 2854

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 8

ER -